{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:56Z","timestamp":1789609136902,"version":"build-2803163510"},"reference-count":26,"publisher":"e-Century Publishing Corporation","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/ssto6670","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T01:21:52Z","timestamp":1735608112000},"page":"7757-7764","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of double filtration plasmapheresis combined with immunosuppressive agents in the treatment of severe lupus nephritis"],"prefix":"10.62347","volume":"16","author":[{"given":"Xia","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/medicina59101841","article-title":"Lupus nephritis in children: novel perspectives","volume":"59","author":"Pennesi","year":"2023","unstructured":"Pennesi M and Benvenuto S. Lupus nephritis in children: novel perspectives. Medicina (Kaunas) 2023; 59: 1841.","journal-title":"Medicina (Kaunas)"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.5958\/0974-360X.2020.00232.2","article-title":"Immunosuppressive therapy of pediatric lupus nephritis","volume":"13","author":"AR","year":"2020","unstructured":"Yulistiani AR, Prasetyo RV and Octavia E. Immunosuppressive therapy of pediatric lupus nephritis. Research Journal of Pharmacy and Technology 2020; 13: 1257-1265.","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/0961203321989808","article-title":"Resolution of huge thrombi in bilateral ventricles caused by severe lupus cardiomyopathy","volume":"30","author":"Liu","year":"2021","unstructured":"Liu X, Lei S, Huang H, Wu Y and Hu ZX. Resolution of huge thrombi in bilateral ventricles caused by severe lupus cardiomyopathy. Lupus 2021; 30: 840-844.","journal-title":"Lupus"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/acr.23792","article-title":"Azathioprine and mycophenolate mofetil adherence patterns and predictors among medicaid beneficiaries with systemic lupus erythematosus","volume":"71","author":"Feldman","year":"2019","unstructured":"Feldman CH, Collins J, Zhang Z, Xu C, Subramanian SV, Kawachi I, Solomon DH and Costenbader KH. Azathioprine and mycophenolate mofetil adherence patterns and predictors among medicaid beneficiaries with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2019; 71: 1419-1424.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0961203320968897","article-title":"Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice - a pilot study","volume":"30","author":"Bukulmez","year":"2021","unstructured":"Bukulmez H, Horkayne-Szakaly I, Bilgin A, Baker TP, Caplan AI and Jones OY. Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice - a pilot study. Lupus 2021; 30: 52-60.","journal-title":"Lupus"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1177\/09612033211034234","article-title":"The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: a retrospective single-center study","volume":"30","author":"Nakagawa","year":"2021","unstructured":"Nakagawa S, Toyama T, Iwata Y, Oshima M, Ogura H, Sato K, Yamamura Y, Miyakawa T, Kitajima S, Hara A, Sakai N, Shimizu M and Wada T. The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: a retrospective single-center study. Lupus 2021; 30: 1739-1746.","journal-title":"Lupus"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/09612033211010338","article-title":"ARID5B rs10821936 and rs10994982 gene polymorphism and susceptibility to juvenile systemic lupus erythematosus and lupus nephritis","volume":"30","author":"Mosaad","year":"2021","unstructured":"Mosaad YM, Hammad A, AlHarrass MF, Sallam R, Shouma A, Hammad E, Ahmed EO, Abdel-Azeem HA, Sherif D, Fawzy I, Elbahnasawy A and Abdel Twab H. ARID5B rs10821936 and rs10994982 gene polymorphism and susceptibility to juvenile systemic lupus erythematosus and lupus nephritis. Lupus 2021; 30: 1226-1232.","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Low ESH, Krishnaswamy G and Thumboo J. Comparing the 1997 update of the 1982 American College of Rheumatology (ACR-97) and the 2012 Systemic Lupus International Collaborating Clinics (SLICC-12) criteria for systemic lupus erythematosus (SLE) classification: which enables earlier classification of SLE in an urban Asian population? Lupus 2019; 28: 11-18.","DOI":"10.1177\/0961203318811599"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/0961203321995251","article-title":"Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis","volume":"30","author":"Das","year":"2021","unstructured":"Das U, Patel R, Guditi S and Taduri G. Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis. Lupus 2021; 30: 876-883.","journal-title":"Lupus"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0961203320981139","article-title":"Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus","volume":"30","author":"Liu","year":"2021","unstructured":"Liu XR, Qi YY, Zhao YF, Cui Y, Wang XY and Zhao ZZ. Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus. Lupus 2021; 30: 412-420.","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0961203320983906","article-title":"Association of coexisting anti-ribosomal P and anti-dsDNA antibodies with histology and renal prognosis in lupus nephritis patients","volume":"30","author":"Wakamatsu","year":"2021","unstructured":"Wakamatsu A, Sato H, Kaneko Y, Cho T, Ito Y, Kurosawa Y, Hasegawa E, Kobayashi D, Nakatsue T, Kuroda T, Suzuki Y, Uchiumi T and Narita I. Association of coexisting anti-ribosomal P and anti-dsDNA antibodies with histology and renal prognosis in lupus nephritis patients. Lupus 2021; 30: 448-458.","journal-title":"Lupus"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1177\/09612033211030559","article-title":"Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus","volume":"30","author":"Fayed","year":"2021","unstructured":"Fayed A, Mohamed A, Ahmed RA, Abouzeid S, Soliman A and Fathy A. Evaluation of urinary FOXP3 mRNA as a biomarker of lupus nephritis in Egyptian patients with systemic lupus erythematosus. Lupus 2021; 30: 1631-1636.","journal-title":"Lupus"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1053\/j.ajkd.2022.10.017","article-title":"Therapeutic plasma exchange: core curriculum 2023","volume":"81","author":"CE","year":"2023","unstructured":"Cervantes CE, Bloch EM and Sperati CJ. Therapeutic plasma exchange: core curriculum 2023. Am J Kidney Dis 2023; 81: 475-492.","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/1744-9987.13548","article-title":"Double filtration plasmapheresis: review of current clinical applications","volume":"25","author":"Hirano","year":"2021","unstructured":"Hirano R, Namazuda K and Hirata N. Double filtration plasmapheresis: review of current clinical applications. Ther Apher Dial 2021; 25: 145-151.","journal-title":"Ther Apher Dial"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1744-9987.14052","article-title":"Double filtration plasmapheresis for bullous pemphigoid: outcomes from the evaluation of eight patients","volume":"27","author":"Kawahira","year":"2023","unstructured":"Kawahira H, Fujii K, Higashi Y, Yamada Y, Mitsuke A, Enokida H and Kanekura T. Double filtration plasmapheresis for bullous pemphigoid: outcomes from the evaluation of eight patients. Ther Apher Dial 2023; 27: 1048-1050.","journal-title":"Ther Apher Dial"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.21037\/tp-22-322","article-title":"Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study","volume":"12","author":"Zhang","year":"2023","unstructured":"Zhang Y, Xie Q, Chen Y, Yang J, Huang S, Deng L and Zhou J. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study. Transl Pediatr 2023; 12: 354-363.","journal-title":"Transl Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/25785826.2024.2372918","article-title":"Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus","volume":"1","author":"Saito","year":"2024","unstructured":"Saito T, Takatsuji R, Murayama G, Yamaji Y, Hagiwara Y, Nishioka Y, Kuga T, Miyashita T, Kusaoi M, Tamura N and Yamaji K. Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus. Immunol Med 2024; 1: 1-11.","journal-title":"Immunol Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/ijn.IJN_64_17","article-title":"Effect of double filtration plasmapheresis on various plasma components and patient safety: a prospective observational cohort study","volume":"27","author":"Jagdish","year":"2017","unstructured":"Jagdish K, Jacob S, Varughese S, David VG, Mohapatra A, Valson A, Tulsidas K, Veerasami T and Alexander S. Effect of double filtration plasmapheresis on various plasma components and patient safety: a prospective observational cohort study. Indian J Nephrol 2017; 27: 377-383.","journal-title":"Indian J Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Garra W, Carmi O, Kivity S and Levy Y. Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag a case series and literature review. Medicine (Baltimore) 2023; 102: e32949.","DOI":"10.1097\/MD.0000000000032949"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1177\/0961203320946372","article-title":"Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus","volume":"29","author":"BG","year":"2020","unstructured":"Hill BG, Hodge B and Misischia R. Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus. Lupus 2020; 29: 1807-1810.","journal-title":"Lupus"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/0961203319829827","article-title":"Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study","volume":"28","author":"Ichinose","year":"2019","unstructured":"Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Koga T, Kawashiri S, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T and Kawakami A. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study. Lupus 2019; 28: 501-509.","journal-title":"Lupus"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.3390\/ijms20246231","article-title":"B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments","volume":"20","author":"Yap","year":"2019","unstructured":"Yap DYH and Chan TM. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. Int J Mol Sci 2019; 20: 6231.","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0961203319890007","article-title":"Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine","volume":"29","author":"Lee","year":"2020","unstructured":"Lee JS, Oh JS, Kim YG, Lee CK, Yoo B and Hong S. Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine. Lupus 2020; 29: 52-57.","journal-title":"Lupus"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"119026","DOI":"10.1016\/j.envpol.2022.119026","article-title":"Sensitive inflammatory biomarkers of acute fine particulate matter exposure among healthy young adults: findings from a randomized, double-blind crossover trial on air filtration","volume":"301","author":"Wen","year":"2022","unstructured":"Wen F, Huang J, Sun Y, Zhao Y, Li B, Wu S and Zhang L. Sensitive inflammatory biomarkers of acute fine particulate matter exposure among healthy young adults: findings from a randomized, double-blind crossover trial on air filtration. Environ Pollut 2022; 301: 119026.","journal-title":"Environ Pollut"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jca.22032","article-title":"Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: a retrospective observational study","volume":"38","author":"Xu","year":"2023","unstructured":"Xu X, Gao C and Han P. Efficacy and cost of double filtration plasmapheresis in severe hypertriglyceridemia-induced pancreatitis: a retrospective observational study. J Clin Apher 2023; 38: 368-375.","journal-title":"J Clin Apher"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s12026-013-8412-0","article-title":"Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study","volume":"56","author":"Hershko","year":"2013","unstructured":"Hershko AY, Scheiman-Elazari A, Aamar S and Naparstek Y. Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study. Immunol Res 2013; 56: 376-81.","journal-title":"Immunol Res"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/12\/ajtr0158535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:08Z","timestamp":1766022968000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/12\/ajtr0158535.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/ssto6670","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}